Dr. Scionti
Contact Dr. Scionti
  • Scionti Prostate Center of Boston

    Ablation Experience: 600+ HIFU cases & 1,000+ Cryo cases
  • Scionti Prostate Center of Boston

    Pioneer Results: A pioneer in new techniques and technology for HIFU and Cryo
  • Scionti Prostate Center of Boston

    Training and Proctoring: National teacher/proctor for HIFU and Cryo
  • Scionti Prostate Center of Boston

    Unique Protocol: Unique total care approach (Staging, Treatment and Follow up)
  • Scionti Prostate Center of Boston

    Patient Access: Praised by patients for his compassion and dedication

Your HIFU Treatment

Who is a Candidate for HIFU with the Sonablate® 500?

  • Dr. Scionti Your HIFU Treatment sonablate-2007-high-res-c.jpgSonablate® 500

    Sonablate® HIFU may be effective for men who have early stage, localized prostate cancer that has not spread or metastasized outside the prostate. I will be happy to discuss your individual medical records and history in order to confirm whether or not you are a candidate for Sonablate® HIFU.

    Sonablate® HIFU may also be an effective therapy for recurrent prostate cancer if you do not any other treatment options. Many patients, who have had primary therapy for prostate cancer, experience a rise in PSA years later and discover that the cancer is back. If that’s the case you may be candidate for the Sonablate® HIFU treatment as well. Send me a completed Patient Information Sheet and we can schedule a telephone consult.

 

Latest News

  • Dr. Scionti MRI Plays Key Role In Future Of Prostate Cancer Treatment drscionti1.png

    MRI Plays Key Role In Future Of Prostate Cancer Treatment

    New Article Supports Alternative To Surgery

    Dr. Stephen Scionti, Founder and Director of the Scionti Prostate Center of Boston, has co-authored a new article on the role of MRI (Magnetic Resonance Imaging) in identifying and treating early stage prostate cancer patients while greatly reducing or even eliminating the risk of damaging side effects from radical surgery.

    Click here